Glenmark’s licensing deal with Novartis to distribute three respiratory drugs in Brazil
Glenmark Farmacêutica, has entered into an exclusive partnership agreement with Novartis to distribute latter’s three respiratory products in Brazil. Under the terms... Read More
What is CRL – Complete Response Letter by USFDA?
Complete response letter is issued by USFDA to new drug / abbreviated application holder, if they determines that we will not approve... Read More
Case Study: Vyleesi™ (Bremelanotide Injection) for HSDD in Premenopausal Women
Posted on24 Jun 2019
Comments0
U.S. Food and Drug Administration (FDA) has approved Vyleesi™ (bremelanotide injection), a melanocortin receptor agonist, to treat acquired, generalized hypoactive sexual desire... Read More
FDA Approval of sNDA for DEXTENZA for the Treatment of Ocular Inflammation Following Ophthalmic Surgery
U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for DEXTENZA to include the treatment of ocular inflammation... Read More